Cargando…
Amid COVID-19 crisis, pain therapeutics telehealth services by pharmacist clinicians fill unique void and mitigate risk
Patients with chronic pain syndromes are facing additional challenges from syndrome coronavirus 2 (SARS-CoV-2) virus compared with the general population. New reasons for compounded social isolation and commensurate opioid dose creeping and suicidality/anxiety, difficulty in obtaining legitimate med...
Autores principales: | Bettinger, Jeffrey, Cleary, Jacqueline, Fudin, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413620/ https://www.ncbi.nlm.nih.gov/pubmed/36204089 http://dx.doi.org/10.1177/2399202620947035 |
Ejemplares similares
-
Opioid Taper Practices Among Clinicians
por: Persico, Amelia L, et al.
Publicado: (2021) -
Misinterpretation of the “Overdose Crisis” Continues to Fuel Misunderstanding of the Role of Prescription Opioids
por: Bettinger, Jeffrey J, et al.
Publicado: (2022) -
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain
por: Gudin, Jeffrey, et al.
Publicado: (2020) -
Family violence experts in the criminal court: the need to fill the void
por: Henaghan, Mark, et al.
Publicado: (2021) -
The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development
por: Fudin, Jeffrey, et al.
Publicado: (2016)